LevitasBio
Elevate your research with our groundbreaking Levitation Technology. Cell Isolation and Enrichment Done Right.
Elevate your research with our groundbreaking Levitation Technology. Cell Isolation and Enrichment Done Right.
LevitasBio is a pioneer in sample processing and analysis within the life sciences market, offering the revolutionary LeviCell system. This advanced technology allows for cellular research and analysis without altering or damaging the cells, preserving the original samples to provide true biological insights. Founded in 2017 and headquartered in the United States, LevitasBio recently secured a significant $11.76M Venture Round investment on 28 March 2024. With a focus on Analytics and Biotechnology, LevitasBio is poised to elevate research through its groundbreaking Levitation Technology, enabling precise cell isolation and enrichment. This investment underscores the potential and investor confidence in LevitasBio's innovative approach to advancing cellular research and analysis.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $11.76M | - | 28 Mar 2024 | |
| Series C | $35.00M | 3 |
|
24 Oct 2022 |
| Series B | $18.00M | 1 |
|
05 Jan 2021 |
| Series A | $8.00M | 1 |
|
03 Aug 2017 |
No recent news or press coverage available for LevitasBio.
We care about your data, and we'd love to use cookies make your experience better.
